Stay updated on Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No substantive changes detected in core study information (inclusion criteria, outcomes, enrollment, locations, or investigators); the two screenshots show the same study details with only minor formatting differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:54:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Core content now includes an important government-operating-status notice and the site version is updated to v3.2.0, replacing the previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:17:03.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.1.0 (replacing Revision: v3.0.2).
    Difference
    0.1%
    Check dated 2025-09-29T04:56:43.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.0.1 to v3.0.2. The 'Back to Top' navigation link was removed, a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-14T23:12:27.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T19:48:28.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as various medical terms related to proteins and antibodies. Notably, previous content related to specific cancer topics and certain antineoplastic agents has been removed.
    Difference
    2%
    Check dated 2025-08-31T12:28:31.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.